Syncona leads Freeline's £88M series B

By Jennie Walters | Jun 19, 2018 | 8:44 PM GMT

Freeline Therapeutics Ltd. (London, U.K.) raised £88.4 million ($116.9 million) in a series B round which included £85

Read the full 185 word article

How to gain access

Continue reading with a
two-week free trial.